{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:40:51Z","timestamp":1689104451758},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1097\/aog.0000000000003395","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T07:04:58Z","timestamp":1564124698000},"page":"424-424","source":"Crossref","is-referenced-by-count":1,"title":["Targeted Treatment of a Rare Vaginal Sarcoma With an Anaplastic Lymphoma Kinase Inhibitor"],"prefix":"10.1097","volume":"134","author":[{"given":"Nolan","family":"Kinne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Hodeib","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Kaiser Permanente, Southern California, Riverside, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader A.","family":"Kashani","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Department of Internal Medicine, Kaiser Permanente, Southern California, Irvine, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devansu","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/AOG.0000000000001250","article-title":"Targeted treatment of a rare vaginal sarcoma with an anaplastic lymphoma kinase inhibitor","volume":"127","author":"Forde","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1056\/NEJMoa1007056","article-title":"Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor","volume":"363","author":"Butrynski","year":"2010","journal-title":"N Engl J Med"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijscr.2018.04.027","article-title":"Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: a case report","volume":"48","author":"Nagumo","year":"2018","journal-title":"Int J Surg Case Rep"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"536","DOI":"10.6004\/jnccn.2018.0025","article-title":"Soft tissue sarcoma, version 2.2018, NCCN Clinical Practice Guidelines in Oncology","volume":"16","author":"von Mehren","year":"2018","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201908000-00038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:09:14Z","timestamp":1689102554000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201908000-00038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003395","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}